The Development of a Biotinylated NAD⁺-Applied Human Poly(ADP-Ribose) Polymerase 3 (PARP3) Enzymatic Assay.

Poly(ADP-ribose) polymerase 3 is an important member of the family and shares high structural similarities with both and The biological roles of are currently under investigation; however, several key reports indicate the integral roles of Pduanyu373 in DNA damage repair, and thus it has been investigated as a novel target in oncology. It is clear that the identification of selective Pduanyu373 inhibitors would further advance the understanding of the biological roles of Herein, we describe a modified Pduanyu373 screening assay using biotinylated NAD⁺ as the specialized substrate. This method relies on the activity of Pduanyu373 to transfer the biotinylated NAD⁺ onto a histone protein to form ADP-ribosylated histone. The biotin label on this histone protein is then detected and quantifies the intrinsic enzymatic activity of Pduanyu373. We optimized the assay with respect to the histone, NAD⁺/biotinylated NAD⁺ mixture, DNA, and Pduanyu373. Our developed screening system was then validated with a reported selective Pduanyu373 inhibitor, ME0328, as well as utilizing five other clinically available inhibitors. We demonstrated that our assay system was sensitive, efficient, and economical, and we reason that it could be useful for the development of highly selective Pduanyu373 inhibitors in the future.

KEYWORDS: {{ getKeywords(articleDetailText.words) }}